
### [MONDO:0000192](http://purl.obolibrary.org/obo/MONDO_0000192)
**Label:** polyglucosan body myopathy

**Subclasses:** [MONDO:0014389](http://purl.obolibrary.org/obo/MONDO_0014389) (polyglucosan body myopathy 1 with or without immunodeficiency), [MONDO:0018348](http://purl.obolibrary.org/obo/MONDO_0018348) (polyglucosan body myopathy type 1), [MONDO:0017992](http://purl.obolibrary.org/obo/MONDO_0017992) (autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis), [MONDO:0014526](http://purl.obolibrary.org/obo/MONDO_0014526) (polyglucosan body myopathy type 2), 

**Mapped go classes:** [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0008466](http://purl.obolibrary.org/obo/GO_0008466) (glycogenin glucosyltransferase activity), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0060546](http://purl.obolibrary.org/obo/GO_0060546) (negative regulation of necroptotic process), [GO:0051321](http://purl.obolibrary.org/obo/GO_0051321) (meiotic cell cycle), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0043130](http://purl.obolibrary.org/obo/GO_0043130) (ubiquitin binding), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0050852](http://purl.obolibrary.org/obo/GO_0050852) (T cell receptor signaling pathway), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0016757](http://purl.obolibrary.org/obo/GO_0016757) (transferase activity, transferring glycosyl groups), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0048701](http://purl.obolibrary.org/obo/GO_0048701) (embryonic cranial skeleton morphogenesis), [GO:0042346](http://purl.obolibrary.org/obo/GO_0042346) (positive regulation of NF-kappaB import into nucleus), [GO:0005536](http://purl.obolibrary.org/obo/GO_0005536) (glucose binding), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0043161](http://purl.obolibrary.org/obo/GO_0043161) (proteasome-mediated ubiquitin-dependent protein catabolic process), [GO:0005978](http://purl.obolibrary.org/obo/GO_0005978) (glycogen biosynthetic process), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0097039](http://purl.obolibrary.org/obo/GO_0097039) (protein linear polyubiquitination), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:2001238](http://purl.obolibrary.org/obo/GO_2001238) (positive regulation of extrinsic apoptotic signaling pathway), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), 

**Class expressions from DL-Learner:**

- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 54.55%
- Thing 52.12%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000745](http://purl.obolibrary.org/obo/GO_2000745) (obsolete positive regulation of transcription from RNA polymerase III promoter involved in smooth muscle cell differentiation)) 39.90%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) and ([GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component) or [GO:2000695](http://purl.obolibrary.org/obo/GO_2000695) (null)) 39.90%


